Is it possible to train the body to resist seasonal allergies? That’s the hope promised by a new line of immunotherapy ...

Phase 3 data show lebrikizumab improves skin clearance and itch in children with moderate to severe atopic dermatitis, ...

Is it possible to train the body to resist seasonal allergies? That’s the hope promised by a new line of immunotherapy reviving an old treatment.

In addition to new medications to treat this enzyme deficiency, research is underway on easier hormone sampling and fixing the gene mutation that causes CAH.

Diagnostic considerations and treatment differ in a few key ways for pediatric cases ...